Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for ZYME

Stock NameZymeworks Inc. Common Stock
TickerZYME(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINCA98985W1023

Show aggregate ZYME holdings

News associated with ZYME

Analysts Predict 13% Gains Ahead For ISCG
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:09:20
Citigroup Increases Zymeworks (NYSE:ZYME) Price Target to $22.00
Zymeworks (NYSE:ZYME – Get Free Report) had its price objective hoisted by Citigroup from $19.00 to $22.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s target price points to a potential upside of 68.97% from the stock’s previous close. A […] - 2025-08-13 02:46:43
Zymeworks (NASDAQ:ZYME) Downgraded to Hold Rating by Wall Street Zen
Zymeworks (NASDAQ:ZYME – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday. Zymeworks Price Performance Shares of ZYME stock opened at $12.02 on Friday. The stock has a market cap of $837.55 million, a P/E ratio of […] - 2025-08-11 02:58:46
Cwm LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME)
Cwm LLC increased its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 1,091.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,299 shares of the company’s stock after acquiring an additional 2,106 shares during the quarter. Cwm LLC’s holdings in Zymeworks […] - 2025-08-06 04:27:03
Zymeworks Inc. (NYSE:ZYME) Receives $21.00 Average Price Target from Analysts
Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the […] - 2025-06-24 02:16:45
Ritholtz Wealth Management Decreases Holdings in Zymeworks Inc. (NYSE:ZYME)
Ritholtz Wealth Management lessened its stake in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 18.8% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 60,494 shares of the company’s stock after selling 13,972 shares during the quarter. Ritholtz Wealth Management’s holdings in Zymeworks were worth $720,000 as of its most recent filing […] - 2025-06-19 05:00:55
Assenagon Asset Management S.A. Sells 147,184 Shares of Zymeworks Inc. (NYSE:ZYME)
Assenagon Asset Management S.A. cut its position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 22.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 495,067 shares of the company’s stock after selling 147,184 shares during the quarter. Assenagon Asset Management S.A. […] - 2025-06-15 05:44:57
Public Employees Retirement System of Ohio Sells 10,400 Shares of Zymeworks Inc. (NYSE:ZYME)
Public Employees Retirement System of Ohio lessened its stake in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 17.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 50,583 shares of the company’s stock after selling 10,400 shares during the period. Public Employees Retirement System of Ohio’s holdings in Zymeworks were worth $741,000 as […] - 2025-06-04 04:56:48
Nuveen Asset Management LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME)
Nuveen Asset Management LLC boosted its stake in Zymeworks Inc. (NYSE:ZYME – Free Report) by 0.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 207,023 shares of the company’s stock after acquiring an additional 886 shares during the period. Nuveen Asset Management LLC’s holdings in Zymeworks were worth $3,031,000 at the end […] - 2025-06-03 04:53:06
Analysts Set Zymeworks Inc. (NYSE:ZYME) Target Price at $21.00
Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have received an average rating of “Moderate Buy” from the ten research firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-05-30 03:06:52
Zymeworks (NYSE:ZYME) Stock Price Up 4.2% After Insider Buying Activity
Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) shot up 4.2% during trading on Tuesday after an insider bought additional shares in the company. The company traded as high as $12.22 and last traded at $12.32. 24,363 shares traded hands during trading, a decline of 96% from the average session volume of 596,591 shares. […] - 2025-05-22 02:32:57
Schonfeld Strategic Advisors LLC Invests $334,000 in Zymeworks Inc. (NYSE:ZYME)
Schonfeld Strategic Advisors LLC purchased a new stake in Zymeworks Inc. (NYSE:ZYME – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,800 shares of the company’s stock, valued at approximately $334,000. A number of other […] - 2025-05-13 04:44:53
Barclays PLC Purchases 66,506 Shares of Zymeworks Inc. (NYSE:ZYME)
Barclays PLC raised its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 43.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 220,890 shares of the company’s stock after purchasing an additional 66,506 shares during the quarter. Barclays PLC’s holdings in Zymeworks […] - 2025-04-29 05:22:53
Legal & General Group Plc Acquires 2,590 Shares of Zymeworks Inc. (NYSE:ZYME)
Legal & General Group Plc increased its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 5.8% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 47,082 shares of the company’s stock after buying an additional 2,590 shares during the quarter. Legal & General Group Plc’s holdings […] - 2025-04-29 04:50:50
Russell Investments Group Ltd. Cuts Stake in Zymeworks Inc. (NYSE:ZYME)
Russell Investments Group Ltd. reduced its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 9.7% during the fourth quarter, Holdings Channel reports. The fund owned 44,945 shares of the company’s stock after selling 4,826 shares during the period. Russell Investments Group Ltd.’s holdings in Zymeworks were worth $658,000 at the end of […] - 2025-04-23 05:20:54
Geode Capital Management LLC Reduces Stock Position in Zymeworks Inc. (NYSE:ZYME)
Geode Capital Management LLC trimmed its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 3.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 689,884 shares of the company’s stock after selling 24,031 shares during the period. Geode Capital Management LLC’s holdings in Zymeworks were worth $10,100,000 as of its […] - 2025-04-23 04:27:03
Renaissance Technologies LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME)
Renaissance Technologies LLC increased its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 54.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 285,700 shares of the company’s stock after buying an additional 101,100 shares during the quarter. Renaissance Technologies […] - 2025-04-22 05:04:52
XTX Topco Ltd Invests $493,000 in Zymeworks Inc. (NYSE:ZYME)
XTX Topco Ltd acquired a new position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 33,702 shares of the company’s stock, valued at approximately $493,000. Other hedge funds have also made changes to their positions in the […] - 2025-04-21 05:44:47
Federated Hermes Inc. Has $2.66 Million Holdings in Zymeworks Inc. (NYSE:ZYME)
Federated Hermes Inc. grew its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 181,626 shares of the company’s stock after buying an additional 3,367 shares during the period. Federated […] - 2025-04-14 05:15:00
Zymeworks Inc. (NYSE:ZYME) Director Ecor1 Capital, Llc Purchases 196,438 Shares
Zymeworks Inc. (NYSE:ZYME – Get Free Report) Director Ecor1 Capital, Llc purchased 196,438 shares of the firm’s stock in a transaction that occurred on Friday, April 4th. The stock was acquired at an average price of $11.17 per share, with a total value of $2,194,212.46. Following the completion of the purchase, the director now owns […] - 2025-04-09 05:05:20
Zymeworks Inc. (NYSE:ZYME) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating on […] - 2025-04-07 03:06:59
Schroder Investment Management Group Acquires New Shares in Zymeworks Inc. (NYSE:ZYME)
Schroder Investment Management Group bought a new position in Zymeworks Inc. (NYSE:ZYME – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 337,161 shares of the company’s stock, valued at approximately $4,892,000. A number of other hedge funds have also added to […] - 2025-04-06 05:29:07
Zymeworks (NYSE:ZYME) Coverage Initiated by Analysts at Lifesci Capital
Lifesci Capital initiated coverage on shares of Zymeworks (NYSE:ZYME – Free Report) in a research note published on Tuesday,Benzinga reports. The brokerage issued an outperform rating and a $30.00 target price on the stock. A number of other research analysts have also recently commented on ZYME. JPMorgan Chase & Co. upgraded Zymeworks from a “neutral” […] - 2025-03-12 05:08:49
HC Wainwright Issues Positive Forecast for Zymeworks (NYSE:ZYME) Stock Price
Zymeworks (NYSE:ZYME – Free Report) had its target price raised by HC Wainwright from $12.00 to $13.00 in a research note issued to investors on Monday,Benzinga reports. HC Wainwright currently has a neutral rating on the stock. ZYME has been the topic of several other research reports. Wells Fargo & Company raised their price target […] - 2025-03-11 04:02:50
Citigroup Forecasts Strong Price Appreciation for Zymeworks (NYSE:ZYME) Stock
Zymeworks (NYSE:ZYME – Free Report) had its target price raised by Citigroup from $18.00 to $19.00 in a report released on Friday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. A number of other research firms have also weighed in on ZYME. Wells Fargo & Company raised their target price on Zymeworks […] - 2025-03-10 04:44:48
New York State Common Retirement Fund Purchases 4,000 Shares of Zymeworks Inc. (NYSE:ZYME)
New York State Common Retirement Fund lifted its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 42.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,371 shares of the company’s stock after buying an additional 4,000 shares during the period. […] - 2025-03-06 08:19:23
Zymeworks Inc. (NYSE:ZYME) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation […] - 2025-02-21 05:10:59

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc ZYME holdings

DateNumber of ZYME Shares HeldBase Market Value of ZYME SharesLocal Market Value of ZYME SharesChange in ZYME Shares HeldChange in ZYME Base ValueCurrent Price per ZYME Share HeldPrevious Price per ZYME Share Held
2025-09-26 (Friday)64,536USD 1,071,298USD 1,071,298
2025-09-25 (Thursday)64,536USD 1,042,902ZYME holding decreased by -9035USD 1,042,9020USD -9,035 USD 16.16 USD 16.3
2025-09-24 (Wednesday)64,536USD 1,051,937USD 1,051,937
2025-09-17 (Wednesday)64,116USD 1,017,521ZYME holding increased by 1924USD 1,017,5210USD 1,924 USD 15.87 USD 15.84
2025-09-16 (Tuesday)64,116USD 1,015,597USD 1,015,597
2025-09-12 (Friday)63,696USD 1,002,575USD 1,002,575
2025-09-11 (Thursday)63,696ZYME holding increased by 840USD 1,039,519ZYME holding increased by 84736USD 1,039,519840USD 84,736 USD 16.32 USD 15.19
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ZYME by Blackrock for IE00B3VWM098

Show aggregate share trades of ZYME

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-11BUY840 16.320* 13.06
2025-08-21SELL-234 14.390* 13.06 Profit of 3,055 on sale
2025-07-31BUY702 12.560* 13.05
2025-06-30SELL-468 12.550* 13.00 Profit of 6,084 on sale
2025-06-25SELL-234 12.710* 13.01 Profit of 3,044 on sale
2025-06-20SELL-468 12.480* 13.02 Profit of 6,093 on sale
2025-05-30SELL-23,380 11.430* 13.09 Profit of 306,025 on sale
2025-05-23BUY316 11.540* 13.16
2025-05-19SELL-316 11.820* 13.20 Profit of 4,172 on sale
2025-05-15SELL-948 11.530* 13.23 Profit of 12,543 on sale
2025-05-12SELL-316 12.020* 13.27 Profit of 4,195 on sale
2025-05-09SELL-316 11.305* 13.29 Profit of 4,200 on sale
2025-04-30SELL-316 13.010* 13.36 Profit of 4,222 on sale
2025-04-24SELL-632 12.520* 13.39 Profit of 8,461 on sale
2025-04-17SELL-316 11.530* 13.47 Profit of 4,256 on sale
2025-04-15SELL-948 10.940* 13.52 Profit of 12,817 on sale
2025-04-14SELL-948 11.000* 13.55 Profit of 12,843 on sale
2025-04-09SELL-1,264 10.000* 13.67 Profit of 17,276 on sale
2025-04-07SELL-2,219 10.430* 13.75 Profit of 30,508 on sale
2025-04-04SELL-3,170 10.950* 13.78 Profit of 43,688 on sale
2025-03-31BUY317 11.910* 13.85
2025-03-19SELL-634 12.790* 13.98 Profit of 8,863 on sale
2025-03-14SELL-1,902 12.250* 14.05 Profit of 26,716 on sale
2025-03-13SELL-636 12.550* 14.07 Profit of 8,947 on sale
2025-03-12SELL-10,812 12.280* 14.09 Profit of 152,382 on sale
2025-03-07SELL-636 12.000* 14.21 Profit of 9,036 on sale
2025-03-06SELL-954 12.130* 14.24 Profit of 13,584 on sale
2025-03-03SELL-318 12.740* 14.30 Profit of 4,549 on sale
2025-02-28SELL-1,908 13.400* 14.32 Profit of 27,321 on sale
2025-02-26SELL-318 13.860* 14.34 Profit of 4,561 on sale
2025-02-25SELL-954 13.570* 14.36 Profit of 13,696 on sale
2025-02-18BUY1,590 14.670* 14.36
2025-02-13BUY318 14.620* 14.32
2025-02-12BUY318 14.300* 14.32
2025-02-11BUY954 13.250* 14.35
2025-02-06BUY2,862 14.910* 14.34
2025-01-27BUY318 14.450* 14.28
2024-12-30BUY1,590 14.510* 14.23
2024-12-06BUY1,268 14.250* 14.31
2024-12-05BUY317 14.200* 14.31
2024-12-04BUY1,585 14.110* 14.32
2024-11-29BUY1,585 14.090* 14.34
2024-11-27BUY1,268 14.420* 14.33
2024-11-26BUY317 14.300* 14.33
2024-11-25BUY8,345 14.200* 14.34
2024-11-21BUY1,455 13.680* 14.37
2024-11-20BUY873 14.550* 14.36
2024-11-18BUY3,492 14.910* 14.31
2024-11-12BUY2,328 17.400* 14.10
2024-11-08BUY1,455 16.630* 13.92
2024-11-07BUY4,350 16.770* 13.70
2024-11-06BUY580 15.610* 13.54
2024-10-31BUY290 13.700* 13.26
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ZYME

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1994,1361,600239,51539.3%
2025-09-1887,5070276,41531.7%
2025-09-1778,91712185,26542.6%
2025-09-1648,268096,78349.9%
2025-09-1591,07730160,43556.8%
2025-09-1252,0480124,34741.9%
2025-09-11100,6680235,02542.8%
2025-09-1058,6040142,91641.0%
2025-09-0969,1350136,58750.6%
2025-09-0862,7290164,40338.2%
2025-09-0564,2290206,25531.1%
2025-09-0467,0770153,48143.7%
2025-09-0357,2750125,68945.6%
2025-09-02105,5130205,86951.3%
2025-08-2953,363090,35359.1%
2025-08-2862,796200117,56453.4%
2025-08-2739,838064,38461.9%
2025-08-2650,535078,63164.3%
2025-08-2550,376205104,85648.0%
2025-08-2252,9010140,09237.8%
2025-08-2142,417092,90145.7%
2025-08-2037,91450563,65659.6%
2025-08-1963,1720111,57456.6%
2025-08-1872,6390124,53858.3%
2025-08-1550,4900105,80047.7%
2025-08-1474,408595141,37352.6%
2025-08-13116,1120237,70748.8%
2025-08-1265,3450134,90848.4%
2025-08-1175,5720170,92144.2%
2025-08-08105,3150506,94220.8%
2025-08-0760,0830127,81647.0%
2025-08-06225,620900359,56862.7%
2025-08-0554,3970121,22144.9%
2025-08-0439,683090,91943.6%
2025-08-0140,7900376,65710.8%
2025-07-3121,115071,77429.4%
2025-07-3065,5540129,96050.4%
2025-07-2951,6770112,92145.8%
2025-07-2859,9810107,25355.9%
2025-07-2535,014082,71942.3%
2025-07-2460,8940104,76558.1%
2025-07-2339,5904568,97657.4%
2025-07-2271,3020128,67655.4%
2025-07-2181,3570133,96260.7%
2025-07-1877,15320152,21350.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.